TRIB – trinity biotech plc - american depositary shares (US:NASDAQ)

News

Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor [Yahoo! Finance]
Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Pneumonia Testing Market size is set to grow by USD 807.5 million from 2024-2028, rising prevalence of pneumonia and concerns associated with pneumonia mortality boost the market, Technavio
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com